Sleepiness and Brain Function: The Effect of Armodafinil in Shift Work Sleep Disorder
The investigators hypothesize that in patients with shift work sleep disorder, armodafinil will specifically increase brain activity in the frontal cortex parallel with improvements in deficits of fundamental mechanisms of attention...
Brief Summary
Official Title: “Magnetoencephalographic Imaging of Sleepiness: The Effect of Armodafinil in Shift Work Sleep Disorder”
The investigators hypothesize that in patients with shift work sleep disorder, armodafinil will specifically increase brain activity in the frontal cortex parallel with improvements in deficits of fundamental mechanisms of attention.
- Study Type: Observational
- Study Design: Time Perspective: Prospective
- Study Primary Completion Date: March 2010
Detailed Clinical Trial Description
The current protocol will utilize a paradigm which is well suited to examine frontal attentional neuronal mechanisms by eliciting event related potential components known to reflect automatic stimulus detection as well as involuntary and voluntary attentional processes. The that end the proposed research has two specific aims. 1) Identify what areas of the frontal lobe and corresponding cognitive functions are impacted by excessive sleepiness in shift work sleep disorder and 2) identify specific brain areas affected by armodafinil and their role in improvement of fundamental attentional processes using a complex cognitive task targeting attentional control.
Arms, Groups and Cohorts in this Clinical Trial
- : 1
- Individuals with shift work sleep disorder
- : 2
- Healthy night shift workers without shift work sleep disorder
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Night shift workers with and without shift work sleep disorder.
Exclusion Criteria:
- Secondary condition to shift work sleep disorder.
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: 55 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: Accepts Healthy Volunteers
Clinical Trial Investigator Information
Lead Investigator: Henry Ford Health System Other
Overall Clinical Trial Officials and Contacts
Christopher Drake, Ph.D. Principal Investigator Henry Ford Hospital Sleep Disorders & Research Center
Additional Information
Information obtained from ClinicalTrials.gov on February 12, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00688142
Study ID Number: C10953/6079/ES/US
ClinicalTrials.gov Identifier: NCT00688142
Health Authority: United States: Institutional Review Board
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00688142
